Market closed today (Weekend) · Prices and yields as of last trading day, 06 Nov 2026
Happy Diwali from all of us at RetailBonds
NCD Public Issue

Creditaccess Grameen Limited NCD public issue, Nov 2022

Prospectus filed with BSE on 9 Nov 2022. This issue's prospectus has been filed. BSE filing dates below are not subscription open/close; bidding dates appear when extracted from the prospectus cover.

Issue Rating
AA- / Stable (India Ratings)
Rating of this issue, from the prospectus
Issuer's Rating on Its Listed Bonds
AA- (ICRA)
Latest rating on the issuer's other listed bonds — not this issue's rating
Face Value
₹1,000 per NCD
Minimum Application
10 NCDs (₹10,000)
Security
Secured
Default Series
Series IV
Allotted when an application names no series
Overall Issue Size (incl. green shoe)
₹1,500.00 Cr
Issuer's Active Bonds on File
12
Reg52(4) Payments on File
12
Series Terms 6
SeriesTenorCoupon RateFrequencyEffective Yield
Series I — 9.45% Monthly 9.83%
Series II — — Cumulative (at maturity) 9.83%
Series III — 9.60% Monthly 10.02%
Series IV — — Cumulative (at maturity) 10.02%
Series V — 10.00% Monthly 10.46%
Series VI — — Cumulative (at maturity) 10.46%
Issue Features (from the prospectus)
SecuritySecured, redeemable, non-convertible debentures
Early redemption No call or put option found in the prospectus
Filed Documents
BSE Scrip Code951918
DRHP Filed2022-09-23
Draft Prospectus (DRHP)View document ↗
Final ProspectusView document ↗

Risk warning: This page restates filing data as published by BSE and, where available, terms extracted from the issuer's own prospectus. It is for informational purposes only and does not constitute investment advice, a recommendation to apply for this issue, or a view on allotment. The issue rating shown is the rating of this issue as printed in its prospectus; ratings can change after filing. The issuer's rating on its listed bonds is the latest rating on its other outstanding bonds, not the rating of this issue. Ratings are the opinion of the rating agency, not RetailBonds.in. Verify all details against the linked prospectus before making any decision. See our methodology and full disclaimer.

← NCD Subscription · Filings tracker